Esketamine was introduced to industry about 2019 to the administration of treatment-refractory depression [melancholy not conscious of common remedy]. A lot of what we're hearing about inside the news is ketamine. Ketamine can be an NMDA receptor antagonist, meaning it blocks the N-methyl-D-aspartate neurotransmitter within the brain. It absolutel